Biolidics Statistics

Total Valuation

Biolidics has a market cap or net worth of SGD 16.91 million. The enterprise value is 19.17 million.

Market Cap	16.91M
Enterprise Value	19.17M

Important Dates

The last earnings date was Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Biolidics has 1.69 billion shares outstanding. The number of shares has increased by 53.94% in one year.

Current Share Class	n/a
Shares Outstanding	1.69B
Shares Change (YoY)	+53.94%
Shares Change (QoQ)	+1.74%
Owned by Insiders (%)	50.47%
Owned by Institutions (%)	2.85%
Float	818.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.80
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.83
EV / Sales	14.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.13

Current Ratio	0.13
Quick Ratio	0.07
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-54.09

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-120.35%
Return on Capital (ROIC)	n/a
Revenue Per Employee	85,467
Profits Per Employee	-187,267
Employee Count	15
Asset Turnover	0.83
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-37.50%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	56.62
Average Volume (20 Days)	1,511,695

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biolidics had revenue of SGD 1.28 million and -2.81 million in losses. Loss per share was -0.00.

Revenue	1.28M
Gross Profit	579,000
Operating Income	-2.98M
Pretax Income	-2.95M
Net Income	-2.81M
EBITDA	-2.97M
EBIT	-2.98M
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 166,000 in cash and 2.43 million in debt, giving a net cash position of -2.27 million or -0.00 per share.

Cash & Cash Equivalents	166,000
Total Debt	2.43M
Net Cash	-2.27M
Net Cash Per Share	-0.00
Equity (Book Value)	-2.81M
Book Value Per Share	-0.00
Working Capital	-2.80M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.03M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 45.16%, with operating and profit margins of -232.06% and -219.11%.

Gross Margin	45.16%
Operating Margin	-232.06%
Pretax Margin	-230.03%
Profit Margin	-219.11%
EBITDA Margin	-231.59%
EBIT Margin	-232.06%
FCF Margin	n/a

Dividends & Yields

Biolidics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.94%
Shareholder Yield	-53.94%
Earnings Yield	-37.78%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biolidics has an Altman Z-Score of -217.72. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-217.72
Piotroski F-Score	n/a